Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Hovione LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for 1474034-05-3 / Omaveloxolone API manufacturers, exporters & distributors?

Omaveloxolone manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Omaveloxolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Omaveloxolone manufacturer or Omaveloxolone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Omaveloxolone manufacturer or Omaveloxolone supplier.

PharmaCompass also assists you with knowing the Omaveloxolone API Price utilized in the formulation of products. Omaveloxolone API Price is not always fixed or binding as the Omaveloxolone Price is obtained through a variety of data sources. The Omaveloxolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Omaveloxolone

Synonyms

1474034-05-3, Rta-408, Rta 408, Nrf1-activator-1, Omaveloxolone [inn], Rta408

Cas Number

1474034-05-3

Unique Ingredient Identifier (UNII)

G69Z98951Q

About Omaveloxolone

Omaveloxolone is a member of the synthetic oleanane triterpenoid class of compounds and an activator of nuclear factor erythroid 2 [NF-E2]-related factor 2 (Nrf2, Nfe2l2), with potential chemopreventive activity. Upon administration, omaveloxolone activates the cytoprotective transcription factor Nrf2. In turn, Nrf2 translocates to the nucleus, dimerizes with a small Maf protein (sMaf), and binds to the antioxidant response element (ARE). This induces the expression of a number of cytoprotective genes, including NAD(P)H quinone oxidoreductase 1 (NQO1), sulfiredoxin 1 (Srxn1), heme oxygenase-1 (HO1, HMOX1), superoxide dismutase 1 (SOD1), gamma-glutamylcysteine synthetase (gamma-GCS), thioredoxin reductase-1 (TXNRD1), glutathione S-transferase (GST), glutamate-cysteine ligase catalytic subunit (Gclc) and glutamate-cysteine ligase regulatory subunit (Gclm), and increases the synthesis of the antioxidant glutathione (GSH). Nrf2, a leucine zipper transcription factor, plays a key role in the maintenance of redox balance and cytoprotection against oxidative stress.

Omaveloxolone Manufacturers

A Omaveloxolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omaveloxolone, including repackagers and relabelers. The FDA regulates Omaveloxolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omaveloxolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Omaveloxolone Suppliers

A Omaveloxolone supplier is an individual or a company that provides Omaveloxolone active pharmaceutical ingredient (API) or Omaveloxolone finished formulations upon request. The Omaveloxolone suppliers may include Omaveloxolone API manufacturers, exporters, distributors and traders.

Omaveloxolone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Omaveloxolone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Omaveloxolone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Omaveloxolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Omaveloxolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Omaveloxolone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Omaveloxolone suppliers with NDC on PharmaCompass.

Omaveloxolone Manufacturers | Traders | Suppliers

Omaveloxolone Manufacturers, Traders, Suppliers 1
98

We have 1 companies offering Omaveloxolone

Get in contact with the supplier of your choice:

  1. Hovione
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.